As the aging population continues to grow – projected to be more than 20% of the U.S. by 2030 – remote patient monitoring is becoming an increasingly important healthcare option. A recent industry ...
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...
Continuous cardiovascular monitoring is vital for preventing and managing heart disease, yet most wearable devices struggle with motion artifacts and require precise alignment over arteries. The newly ...
iRhythm Technologies, Inc. IRTC has received regulatory approval from Japan’s Pharmaceutical and Medical Device Agency for its Zio long-term continuous ECG monitoring (LTCM) system. The Zio system, ...
iRhythm Technologies announced it has received another FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System that works with a wearable to monitor patients with atrial fibrillation, ...
Cardiovascular diseases remain the leading global cause of mortality, claiming nearly 18 million lives each year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results